Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon

Bone Marrow Transplantation

Volumn 26, Issue 11, 2000, Pages 1165-1172

  McBride, N C ^a   Cavenagh, J D ^a   Newland, A C ^a   Lillington, D M ^b   Murrell, C ^a   Kelsey, S M ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

CML; Peripheral blood stem cell transplantation; IFN

Indexed keywords

ALPHA INTERFERON; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; BCR ABL PROTEIN; BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; HYDROXYUREA; IDARUBICIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BLOOD TOXICITY; BONE MARROW RESCUE; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER REGRESSION; CANCER SURVIVAL; CHROMOSOME ANALYSIS; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL TOXICITY; GRAFT VERSUS HOST REACTION; HEADACHE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKAPHERESIS; MALE; MUCOSA INFLAMMATION; MYCOSIS; PERIPHERAL BLOOD STEM CELL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RASH; STAPHYLOCOCCUS INFECTION; STATISTICAL ANALYSIS; STEM CELL; SURVIVAL TIME; TREATMENT FAILURE;

EID: 0033671356     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702671     Document Type: Article

References (20)

1. Treatment of CGL in chronic phase by allogeneic BMT
2. Treatment of CML with allogeneic BMT after preparation with BuCy2
3. Long term marrow culture reveals chromosomally normal haemopoietic progenitor cells in patients with Ph+ve CML
4. Autografting for CGL in chronic phase: An update
5. Autografting with cultured marrow in chronic myeloid leukaemia: Results of a pilot study
6. Autologous transplants for chronic myelogenous leukaemia: Results from eight transplant groups
7. Mobilisation of Ph-negative progenitors into peripheral blood in chronic myeloid leukaemia
8. Mobilisation and transplantation of Philadelphia negative peripheral blood progenitor cells early in chronic myelogenous leukaemia
9. Autologous transplantation in chronic myeloid leukaemia using peripheral blood stem cells. Short report
10. Autografting with Philadelphia chromosome-negative mobilised haematopoietic progenitor cells in chronic myelogenous leukaemia
11. Haematological remission and cytogenetic improvement induced by recombinant human interferon alpha in CML
12. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukaemia
13. UK medical research council randomised multicentre trial of interferon α for chronic myeloid leukaemia: Improved survival irrespective of cytogenetic response
14. Prolonged survival in chronic myelogenous leukaemia after cytogenetic response to interferon-α therapy
15. A new prognostic score for survival of patients with chronic myeloid leukaemia treated with interferon alfa
16. Interferon alfa-2b combined with cytarabine vs interferon alone in chronic myeloid leukaemia
17. Detection of residual leukaemia after bone marrow transplant for chronic myeloid leukaemia: Role of polymerase chain reaction in predicting relapse
18. Mobilisation of Philadelphia negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alpha
19. ICE, mini ICE or high-dose hydroxyurea to mobilise Philadelphia negative PBPC in chronic myelogenous leukaemia
20. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukeamia